STAAR Surgical (NASDAQ: STAA) reported Q3 EPS of $0.20, $0.02 better than the analyst estimate of $0.18. Revenue for the quarter came in at $88.6 million versus the consensus estimate of $86.9 million.

GUIDANCE:

STAAR Surgical sees FY2024 revenue of $340-345 million, versus the consensus of $343.4 million. Adjusted EBITDA of approximately $42 million and Adjusted EBITDA per diluted share of approximately $0.80.

For earnings history and earnings-related data on STAAR Surgical (STAA) click here.